. Therefore, we examined whether NMN could protect against ischemic brain damage. Mice were subjected to transient forebrain ischemia and treated with NMN or vehicle at the start of reperfusion or 30 min after the ischemic insult. At 2, 4, and 24 h of recovery, the proteins poly-ADP-ribosylation (PAR), hippocampal NAD + levels, and expression levels of NAD + salvage pathway enzymes were determined. Furthermore, animal's neurologic outcome and hippocampal CA1 neuronal death was assessed after six days of reperfusion. NMN (62.5 mg/kg) dramatically ameliorated the hippocampal CA1 injury and significantly improved the neurological outcome. Additionally, the post-ischemic NMN treatment prevented the increase in PAR formation and NAD + catabolism. Since the NMN administration did not affect animal's temperature, blood gases or regional cerebral blood flow during recovery, the protective effect was not a result of altered reperfusion conditions. These data suggest that administration of NMN at a proper dosage has a strong protective effect against ischemic brain injury.
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Introduction
One of the pathologic outcomes after ischemic insult is the free radical induced DNA damage that activates the nuclear enzyme poly(ADPribose) polymerase 1 (PARP1) (Endres et al., 1997; Strosznajder et al., 2003) , for review see (Chiarugi, 2005 , 1997; Liu et al., 2009) . NAD + can be generated in cells either by de novo synthesis from tryptophan or it is re-synthesized from nicotinamide (Nam) via a salvage pathway (Belenky et al., 2007; Owens et al., 2013b) . Majority of the NAD + is replenished by the salvage pathway since Nam is the byproduct of the NAD + catabolizing enzymes (Magni et al., 1999; Imai, 2009; Owens et al., 2013b) . The salvage pathway represents two enzymatic reactions. In the first step, Nam is converted to nicotinamide mononucleotide (NMN) by nicotinamide phosphoribosyltransferase (Nampt) (Revollo et al., 2004) , also known as pre-B-cell colony-enhancing factor (PBEF). NMN is then adenylylated to form NAD + by nicotinamide nucleotide adenylyltransferase (Nmnat) (Belenky et al., 2007 
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